Thus, since it is now clear that the HSP60 protein loaded into H. capsulatum EVs is a major player in the survival rate of the pathogen in the host, it could represent one of the most important targets for antibody-based therapy against histoplasmosis. This evidence concerns the gene HSPD1 and histoplasmosis.